Synthetic Biologics - Stock Price History | SYN

Historical daily share price chart and data for Synthetic Biologics since 2020 adjusted for splits. The latest closing stock price for Synthetic Biologics as of February 28, 2020 is 0.43.
  • The all-time high Synthetic Biologics stock closing price was 787.84 on January 09, 2007.
  • The Synthetic Biologics 52-week high stock price is 0.85, which is 97.7% above the current share price.
  • The Synthetic Biologics 52-week low stock price is 0.36, which is 16.3% below the current share price.
  • The average Synthetic Biologics stock price for the last 52 weeks is 0.51.
Synthetic Biologics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 0.5351 0.5907 0.8100 0.3887 0.5069 -9.48%
2018 7.3799 18.3531 20.1014 0.5211 0.5600 -96.85%
2017 23.9488 30.3497 35.3147 14.8287 17.7622 -33.39%
2016 59.0890 79.3706 95.4545 26.4685 26.6643 -66.70%
2015 83.7725 54.1958 139.8601 53.1469 80.0699 56.85%
2014 65.9912 56.2937 120.6294 40.5594 51.0490 -4.58%
2013 55.7585 62.2378 69.9301 34.9650 53.4965 -13.07%
2012 70.8980 44.4056 97.9021 44.4056 61.5385 39.68%
2011 35.4135 47.2028 74.4755 16.2587 44.0559 0.80%
2010 36.6115 24.4755 81.4685 24.4755 43.7063 123.21%
2009 15.3548 5.5944 45.4545 4.5455 19.5804 212.85%
2008 36.6135 180.0699 181.8182 4.5455 6.2587 -96.50%
2007 240.3050 671.3958 787.8410 110.1509 179.0210 -70.32%
2006 451.9100 419.6224 603.2072 419.6224 603.2072 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.007B $0.000B
Synthetic Biologics, Inc. is a biotechnology company focused on the development of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses. The Company is engaged in developing product candidates to treat pulmonary arterial hypertension, relapses in multiple sclerosis, cognitive dysfunction in multiple sclerosis, fibromyalgia and amyotrophic lateral sclerosis. Synthetic Biologics, Inc., formerly known as Adeona Pharmaceuticals, Inc., is headquartered in Ann Arbor, Michigan.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $120.026B 13.72
CSL (CSLLY) Australia $93.989B 0.00
Gilead Sciences (GILD) United States $91.816B 11.83
Vertex Pharmaceuticals (VRTX) United States $57.895B 52.54
Biogen (BIIB) United States $53.974B 9.22
Regeneron Pharmaceuticals (REGN) United States $47.485B 20.11
Illumina (ILMN) United States $38.210B 39.50
Alexion Pharmaceuticals (ALXN) United States $20.389B 9.48
Seattle Genetics (SGEN) United States $18.657B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.001B 0.00
Incyte (INCY) United States $16.440B 35.27
BioMarin Pharmaceutical (BMRN) United States $16.134B 690.92
Genmab (GNMSF) Denmark $14.343B 46.13
Galapagos (GLPG) Belgium $13.996B 30.57
Alnylam Pharmaceuticals (ALNY) United States $12.665B 0.00
Exact Sciences (EXAS) United States $11.959B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.059B 51.67
BeiGene (BGNE) Cayman Islands $9.466B 0.00
Moderna (MRNA) United States $8.804B 0.00
Sarepta Therapeutics (SRPT) United States $8.374B 0.00
QIAGEN (QGEN) Netherlands $8.224B 25.33
BioNTech SE (BNTX) Germany $7.666B 0.00
Bio-Techne Corp (TECH) United States $7.402B 50.66
Guardant Health (GH) United States $7.246B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.469B 17.12
Ascendis Pharma (ASND) Denmark $6.207B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.022B 0.00
Reata Pharmaceuticals (RETA) United States $5.712B 0.00
Exelixis (EXEL) United States $5.625B 18.06
ARGENX SE-ADR (ARGX) Netherlands $5.470B 0.00
Amarin (AMRN) Ireland $5.240B 0.00
Acceleron Pharma (XLRN) United States $4.595B 0.00
China Biologic Products (CBPO) China $4.538B 25.56
Repligen (RGEN) United States $4.484B 82.00
Global Blood Therapeutics (GBT) United States $3.720B 0.00
Bluebird Bio (BLUE) United States $3.714B 0.00
Mirati Therapeutics (MRTX) United States $3.670B 0.00
Adaptive Biotechnologies (ADPT) United States $3.577B 0.00
MorphoSys AG (MOR) Germany $3.452B 0.00
Zai Lab (ZLAB) China $3.253B 0.00
Alkermes (ALKS) Ireland $3.097B 245.38
Ultragenyx Pharmaceutical (RARE) United States $3.076B 0.00
Immunomedics (IMMU) United States $3.029B 0.00
Genmab (GMAB) Denmark $3.010B 11.81
CRISPR Therapeutics AG (CRSP) Switzerland $3.008B 50.97
Blueprint Medicines (BPMC) United States $2.938B 0.00
Emergent Biosolutions (EBS) United States $2.877B 19.97
NeoGenomics (NEO) United States $2.872B 125.04
MyoKardia (MYOK) United States $2.842B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.810B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.805B 0.00
Halozyme Therapeutics (HALO) United States $2.802B 0.00
Amicus Therapeutics (FOLD) United States $2.379B 0.00
UniQure (QURE) Netherlands $2.260B 0.00
Arena Pharmaceuticals (ARNA) United States $2.210B 5.77
RA PHARMCTL INC (RARX) United States $2.193B 0.00
Fate Therapeutics (FATE) United States $2.176B 0.00
Insmed (INSM) United States $2.173B 0.00
Principia Biopharma (PRNB) United States $2.068B 0.00
Eidos Therapeutics (EIDX) United States $1.887B 0.00
Epizyme (EPZM) United States $1.864B 0.00
Denali Therapeutics (DNLI) United States $1.827B 0.00
Ligand Pharmaceuticals (LGND) United States $1.815B 53.01
Alector (ALEC) United States $1.785B 0.00
Arvinas (ARVN) United States $1.599B 0.00
Zymeworks (ZYME) Canada $1.564B 0.00
Akcea Therapeutics (AKCA) United States $1.538B 35.61
REGENXBIO (RGNX) United States $1.505B 0.00
Coherus BioSciences (CHRS) United States $1.346B 16.13
Dicerna Pharmaceuticals (DRNA) United States $1.328B 0.00
Revance Therapeutics (RVNC) United States $1.317B 0.00
Myriad Genetics (MYGN) United States $1.288B 22.74
Zealand Pharma (ZLDPF) Denmark $1.287B 0.00
Zealand Pharma (ZEAL) Denmark $1.255B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.220B 0.00
Editas Medicine (EDIT) United States $1.151B 0.00
Intra-Cellular Therapies (ITCI) United States $1.135B 0.00
Twist Bioscience (TWST) United States $1.073B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.050B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.026B 0.00
Athenex (ATNX) United States $0.972B 0.00
PHARMA MAR SA (PHMMF) Spain $0.932B 0.00
DBV Technologies S.A (DBVT) France $0.912B 0.00
Mesoblast (MESO) Australia $0.859B 0.00
Pharming Group (PHGUF) Netherlands $0.857B 0.00
Cytokineticsorporated (CYTK) United States $0.824B 0.00
Adverum Biotechnologies (ADVM) United States $0.805B 0.00
Codexis (CDXS) United States $0.777B 0.00
Sangamo Therapeutics (SGMO) United States $0.773B 0.00
Heska (HSKA) United States $0.764B 0.00
Vericel (VCEL) United States $0.675B 100.07
Cellectis S.A (CLLS) France $0.672B 0.00
Arcus Biosciences (RCUS) United States $0.661B 0.00
Retrophin (RTRX) United States $0.647B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.640B 0.00
Cara Therapeutics (CARA) United States $0.614B 0.00
Intrexon (PGEN) United States $0.605B 0.00
GENFIT S.A (GNFT) France $0.595B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.590B 5.19
Anika Therapeutics (ANIK) United States $0.587B 20.06
ANI Pharmaceuticals (ANIP) United States $0.583B 10.53
Kadmon Holdings (KDMN) United States $0.578B 0.00
Intellia Therapeutics (NTLA) United States $0.568B 0.00
UROGEN PHARMA (URGN) United States $0.559B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.541B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.519B 0.00
Bellus Health (BLU) Canada $0.509B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.494B 0.00
AC Immune SA (ACIU) Switzerland $0.479B 11.08
Compugen (CGEN) Israel $0.465B 0.00
NantKwest (NK) United States $0.460B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Inovio Pharmaceuticals (INO) United States $0.442B 0.00
BioDelivery Sciences (BDSI) United States $0.433B 0.00
Prothena (PRTA) Ireland $0.431B 0.00
Mersana Therapeutics (MRSN) United States $0.419B 0.00
Cue Biopharma (CUE) United States $0.410B 0.00
Cel-Sci (CVM) United States $0.399B 0.00
AnaptysBio (ANAB) United States $0.396B 0.00
Merus (MRUS) Netherlands $0.392B 0.00
Puma Biotechnology (PBYI) United States $0.391B 0.00
Precision BioSciences (DTIL) United States $0.389B 0.00
PDL BioPharma (PDLI) United States $0.386B 9.66
Adaptimmune Therapeutics (ADAP) United Kingdom $0.383B 0.00
Pfenex (PFNX) United States $0.380B 0.00
Novavax (NVAX) United States $0.379B 0.00
Kindred Biosciences (KIN) United States $0.378B 0.00
Clovis Oncology (CLVS) United States $0.375B 0.00
Agenus (AGEN) United States $0.367B 0.00
Sorrento Therapeutics (SRNE) United States $0.366B 0.00
Avid Bioservices (CDMO) United States $0.359B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.358B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.345B 0.00
Dynavax Technologies (DVAX) United States $0.340B 0.00
CytomX Therapeutics (CTMX) United States $0.324B 0.00
Cellular Biomedicine (CBMG) United States $0.317B 0.00
Gritstone Oncology (GRTS) United States $0.303B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.294B 2.04
Syndax Pharmaceuticals (SNDX) United States $0.292B 0.00
Stemline Therapeutics (STML) United States $0.290B 0.00
Albireo Pharma (ALBO) United States $0.288B 0.00
Syros Pharmaceuticals (SYRS) United States $0.282B 0.00
MannKind (MNKD) United States $0.278B 0.00
OSMOTICA PHARM (OSMT) United States $0.272B 0.00
WAVE Life Sciences (WVE) Singapore $0.269B 0.00
Kamada (KMDA) Israel $0.264B 10.96
Starpharma Holdings (SPHRY) Australia $0.257B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.256B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.247B 0.00
Biofrontera AG (BFRA) Germany $0.246B 0.00
Seres Therapeutics (MCRB) United States $0.239B 0.00
Aduro Biotech (ADRO) United States $0.239B 0.00
VBI Vaccines (VBIV) United States $0.234B 0.00
IVERIC Bio (ISEE) United States $0.224B 0.00
POXEL SA FRANCE (PXXLF) France $0.220B 0.00
Kala Pharmaceuticals (KALA) United States $0.216B 0.00
Sutro Biopharma (STRO) United States $0.213B 0.00
Protagonist Therapeutics (PTGX) United States $0.213B 0.00
XOMA (XOMA) United States $0.208B 0.00
Geron (GERN) United States $0.208B 0.00
Alcobra (ARCT) United States $0.204B 0.00
ChromaDex (CDXC) United States $0.203B 0.00
VTv Therapeutics (VTVT) United States $0.203B 0.00
Prometic Life Sciences (LMNL) Canada $0.201B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.200B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.194B 0.00
Arbutus Biopharma (ABUS) Canada $0.193B 0.00
Athersys (ATHX) United States $0.188B 0.00
Theratechnologies (THTX) Canada $0.181B 0.00
TELA Bio (TELA) United States $0.180B 0.00
Spero Therapeutics (SPRO) United States $0.178B 0.00
Affimed (AFMD) Germany $0.178B 0.00
ADMA Biologics Inc (ADMA) United States $0.173B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.173B 0.00
Exicure (XCUR) United States $0.171B 0.00
Abeona Therapeutics (ABEO) United States $0.169B 0.00
Windtree Therapeutics (WINT) United States $0.164B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.160B 8.23
Dyadic (DYAI) United States $0.158B 0.00
Five Prime Therapeutics (FPRX) United States $0.157B 0.00
Cerecor (CERC) United States $0.156B 0.00
Selecta Biosciences (SELB) United States $0.153B 0.00
Fortress Biotech (FBIO) United States $0.151B 0.00
Strongbridge Biopharma (SBBP) United States $0.146B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.144B 0.00
Verastem (VSTM) United States $0.142B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.139B 0.00
Aptinyx (APTX) United States $0.137B 0.00
VolitionRX (VNRX) Singapore $0.137B 0.00
Antibe Therapeutics (ATBPF) Canada $0.136B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
CorMedix Inc (CRMD) United States $0.133B 0.00
Arsanis (XFOR) United States $0.132B 0.00
Happiness Biotech Group (HAPP) China $0.129B 0.00
ARAVIVE, INC (ARAV) United States $0.128B 0.00
PHASEBIO PHARMA (PHAS) United States $0.126B 0.00
Northwest Biotherapeutics (NWBO) United States $0.125B 0.00
Celyad SA (CYAD) Belgium $0.125B 0.00
Liquidia Technologies (LQDA) United States $0.117B 0.00
Vaccinex (VCNX) United States $0.107B 0.00
AIT Therapeutics (XAIR) United States $0.107B 0.00
Palatin Technologies (PTN) United States $0.106B 2.89
OvaScience (MLND) United States $0.104B 0.00
Enzo Biochem (ENZ) United States $0.100B 0.00
Prima BioMed (IMMP) Australia $0.096B 0.00
Clearside Biomedical (CLSD) United States $0.095B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.094B 0.00
Adocia (ADOCY) France $0.086B 0.00
Applied Genetic Technologies (AGTC) United States $0.085B 0.00
Proteostasis Therapeutics (PTI) United States $0.079B 0.00
SESEN BIO, INC (SESN) United States $0.079B 0.00
Checkpoint Therapeutics (CKPT) United States $0.078B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.075B 0.00
Emmaus Life Sciences (EMMA) United States $0.073B 0.00
Catalyst Biosciences (CBIO) United States $0.069B 0.00
Pluristem Therapeutics (PSTI) Israel $0.068B 0.00
Synlogic (SYBX) United States $0.067B 0.00
Orgenesis (ORGS) United States $0.067B 4.29
Menlo Therapeutics (MNLO) United States $0.066B 0.00
IBio (IBIO) United States $0.066B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.065B 0.00
Acorda Therapeutics (ACOR) United States $0.064B 0.00
Soligenix (SNGX) United States $0.062B 0.00
Trevena (TRVN) United States $0.061B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.060B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.059B 0.00
Protalix BioTherapeutics (PLX) Israel $0.056B 0.00
NewLink Genetics (NLNK) United States $0.055B 0.00
DiaMedica Therapeutics (DMAC) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Advaxis (ADXS) United States $0.047B 0.00
Idera Pharmaceuticals (IDRA) United States $0.044B 0.00
Celldex Therapeutics (CLDX) United States $0.044B 0.00
Curis (CRIS) United States $0.041B 0.00
CollPlant Holdings (CLGN) Israel $0.041B 0.00
Cleveland BioLabs (CBLI) United States $0.041B 0.00
Organovo Holdings (ONVO) United States $0.041B 0.00
TOCAGEN INC (TOCA) United States $0.038B 0.00
AquaBounty Technologies (AQB) United States $0.038B 0.00
AmpliPhi Biosciences (ARMP) United States $0.037B 0.00
Entera Bio (ENTX) Israel $0.036B 0.00
Evogene (EVGN) Israel $0.036B 0.00
Alimera Sciences (ALIM) United States $0.034B 0.00
Celsion (CLSN) United States $0.028B 0.00
Pulmatrix (PULM) United States $0.028B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.026B 0.00
Bionano Genomics (BNGO) United States $0.025B 0.00
Novogen (KZIA) Australia $0.025B 0.00
BioCardia (BCDA) United States $0.025B 0.00
VistaGen Therapeutics (VTGN) United States $0.024B 0.00
Stellar Biotechnologies (EDSA) Canada $0.024B 0.00
Oncobiologics (OTLK) United States $0.023B 0.00
Signal Genetics (MGEN) United States $0.021B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
VIVUS (VVUS) United States $0.020B 0.00
Unum Therapeutics (UMRX) United States $0.020B 0.00
Aptevo Therapeutics (APVO) United States $0.018B 0.00
IMMURON (IMRN) Australia $0.016B 0.00
Aytu Bioscience (AYTU) United States $0.015B 0.00
Titan Pharmaceuticals (TTNP) United States $0.014B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.014B 0.00
Genetic Technologies (GENE) Australia $0.013B 0.00
Cesca Therapeutics (THMO) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
TrovaGene (TROV) United States $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
BioPharmX (BPMX) United States $0.007B 0.00
Neuralstem (SNCA) United States $0.003B 0.00